THE NEWSROOM

Search
Categories
Archives

Investment Monitoring From Robbins LLP

To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.

Adomani, Inc.

Robbins LLP Is Investigating the Officers and Directors of ADOMANI, Inc. (ADOM) on Behalf of Shareholders Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of ADOMANI,

Read More

Ulta Beauty, Inc.

Ulta Beauty, Inc. Accused of Selling Used Products as New Purchasers of Ulta Beauty, Inc. (ULTA) filed a securities class action complaint against the company’s officers and directors for alleged

Read More

Atlas Financial Holdings, Inc.

Atlas Financial Holdings, Inc. Accused of Understating Certain Loss Reserves According to the complaint, throughout the class period, Atlas Financial Holdings, Inc. (NasdaqGM: AFH) attested to the effectiveness of the

Read More

Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc. (EKSO) Accused of Implementing Unreliable Internal Controls According to the complaint, Ekso Bionics Holdings, Inc. (EKSO) repeatedly attested to the accuracy of the company’s financial reporting,

Read More

Syneos Health, Inc.

Syneos Health, Inc. Accused of Misleading Investors About its Merger According to the complaint, on May 10, 2017, Syneos Health, Inc. (SYNH), formerly known as INC Research Holdings, Inc. (“INC”),

Read More

Overstock.com, Inc.

Robbins is Investigating the Officers and Directors of Overstock.com, Inc. Robbins LLP is investigating whether certain officers and directors of Overstock.com, Inc. (NasdaqGM: OSTK) breached their fiduciary duties to shareholders.

Read More

Red Rock Resorts, Inc.

Robbins LLP Is Investigating the Officers and Directors of Red Rock Resorts, Inc. (RRR) on Behalf of Shareholders March 2, 2018 (San Diego, CA & Las Vegas, NV) – Shareholder

Read More

Obalon Therapeutics, Inc.

Obalon Therapeutics, Inc. Accused of Implementing Inadequate Internal Controls Over Financial Reporting On October 5, 2016, Obalon Therapeutics, Inc. held its initial public offering, issuing 5,000,000 shares and raising net

Read More

MiMedx Group, Inc.

MiMedx Group, Inc. Accused of Engaging in Fraudulent Revenue Scheme According to the complaint, in December 2016, two former MiMedx Group, Inc. (MDXG) employees filed a complaint against the company

Read More
Skip to content